{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:48:55Z","timestamp":1773967735772,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,3,31]],"date-time":"2012-03-31T00:00:00Z","timestamp":1333152000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1756-0500-5-169","type":"journal-article","created":{"date-parts":[[2012,3,31]],"date-time":"2012-03-31T12:13:51Z","timestamp":1333196031000},"source":"Crossref","is-referenced-by-count":37,"title":["Inter-relationship of plasma markers of oxidative stress and thyroid hormones in schizophrenics"],"prefix":"10.1186","volume":"5","author":[{"given":"Moses O","family":"Akiibinu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omobola A","family":"Ogundahunsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebenezer O","family":"Ogunyemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,31]]},"reference":[{"key":"1462_CR1","doi-asserted-by":"publisher","first-page":"180","DOI":"10.4103\/0019-5545.55084","volume":"51","author":"JP John","year":"2009","unstructured":"John JP: Fronto - temporal dysfunction in schizophrenia, a selective review. Indian J Psychiatr. 2009, 51: 180-190. 10.4103\/0019-5545.55084.","journal-title":"Indian J Psychiatr"},{"key":"1462_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.pscychresns.2009.04.001","volume":"174","author":"JX Van Snellenberg","year":"2009","unstructured":"Van Snellenberg JX: Working memory and long term memory deficits in schizophrenia; is there a common substrate?. Psychiatry Res. 2009, 174: 89-96. 10.1016\/j.pscychresns.2009.04.001.","journal-title":"Psychiatry Res"},{"key":"1462_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0167-7306(02)35032-4","volume-title":"The lipid hypothesis of schizophrenic in brain lipids and disorders in biological psychiatry","author":"D Horrobin","year":"2002","unstructured":"Horrobin D: The lipid hypothesis of schizophrenic in brain lipids and disorders in biological psychiatry. Edited by: Skinner ER. 2002, Amsterdam: Elsevier Science, 35: 39-52."},{"key":"1462_CR4","volume-title":"Prog Neurobiol","author":"U Meyer","year":"2009","unstructured":"Meyer U, Feldon J: Epidemiology driven neuro-developmental animal models of schizophrenia. Prog Neurobiol. 2009,"},{"key":"1462_CR5","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.encep.2008.02.012","volume":"35","author":"PY LeBee","year":"2009","unstructured":"LeBee PY, Fatseas M, Denis C, Lavic E, Auriacombe M: Cannabis and psychosis; search of a causal link through a critical and systematic review. Enc\u00e9phale. 2009, 35: 377-385.","journal-title":"Enc\u00e9phale"},{"key":"1462_CR6","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(09)60995-8","volume":"374","author":"J Van Os","year":"2009","unstructured":"Van Os J, Kapur S: Schizophrenia. Lancet. 2009, 374: 635-645. 10.1016\/S0140-6736(09)60995-8.","journal-title":"Lancet"},{"key":"1462_CR7","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1053\/jcpa.2001.0465","volume":"124","author":"M Jeffrey","year":"2001","unstructured":"Jeffrey M, Ryder SJ, Martin S, Hawkins SAC, Terry L, Berthelin-Baker C, Bellworthy SJ: Oral inoculation of sheep with the agent of bovine spongiform encephalopathy (BSE). I. Onset and distribution of disease-specific PrP accumulation in brain and viscera. J Comp Pathol. 2001, 124: 280-289. 10.1053\/jcpa.2001.0465.","journal-title":"J Comp Pathol"},{"key":"1462_CR8","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1055\/s-2001-11517","volume":"67","author":"AS Joshi","year":"2001","unstructured":"Joshi AS, Li XC, Nimrod AC, ElSohly HN, Walker LA, Clark AM: Dihydrochalcones from Piper longicaudatum. Planta Med. 2001, 67: 186-188. 10.1055\/s-2001-11517.","journal-title":"Planta Med"},{"key":"1462_CR9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0031-6997(25)06663-3","volume":"43","author":"S Moncada","year":"1991","unstructured":"Moncada S, Palmer RMJ, Higgs EA: Nitric oxide physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991, 43: 109-142.","journal-title":"Pharmacol Rev"},{"key":"1462_CR10","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1164\/ajrccm.149.2.7508323","volume":"149","author":"B Gaston","year":"1994","unstructured":"Gaston B, Drazen JM, Loscalzo J, Stanler JS: The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med. 1994, 149: 538-551.","journal-title":"Am J Respir Crit Care Med"},{"key":"1462_CR11","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/0014-5793(93)81706-6","volume":"334","author":"N Hogg","year":"1993","unstructured":"Hogg N, Kalyanaraman B, Joseph J, Struck A, Parthasarthy S: Inhibition of low-density lipoprotein oxidation by nitric oxide. FEBS Lett. 1993, 334: 170-174. 10.1016\/0014-5793(93)81706-6.","journal-title":"FEBS Lett"},{"key":"1462_CR12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1515\/bchm3.1994.375.2.81","volume":"375","author":"JS Beckman","year":"1994","unstructured":"Beckman JS, Ye YZ, Anderson PG, Chen J, Accavitti MA, Tarpey MM, White CR: Extensive nitration of protein tyrosine in human atheroscerosis detected by immunohistochemistry. Biol Chem Hoppe Seyler. 1994, 375: 81-88.","journal-title":"Biol Chem Hoppe Seyler"},{"key":"1462_CR13","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/379458a0","volume":"379","author":"G Dai","year":"1996","unstructured":"Dai G, Levy O, Carrasco N: Cloning and characterization of the thyroid iodide transporter. Nature. 1996, 379: 458-460. 10.1038\/379458a0.","journal-title":"Nature"},{"key":"1462_CR14","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1006\/excr.2001.5444","volume":"273","author":"X De Deken","year":"2002","unstructured":"De Deken X, Wang D, Dumont JE, Miot F: Characterization of ThOX proteins as components of the thyroid H2O2 -generating system. Exp Cell Res. 2002, 273: 187-196. 10.1006\/excr.2001.5444.","journal-title":"Exp Cell Res"},{"key":"1462_CR15","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1089\/ars.2008.2054","volume":"10","author":"U Schweizer","year":"2008","unstructured":"Schweizer U, Chiu J, Kohrle J: Peroxides and peroxide-degrading enzymes in the thyroid. Antioxid Redox Signal. 2008, 10: 1577-1592. 10.1089\/ars.2008.2054.","journal-title":"Antioxid Redox Signal"},{"key":"1462_CR16","first-page":"189","volume":"26","author":"A Taurog","year":"1970","unstructured":"Taurog A: Thyroid peroxidase and thyroxine biosynthesis. Recent Prog Horm Res. 1970, 26: 189-247.","journal-title":"Recent Prog Horm Res"},{"key":"1462_CR17","volume-title":"J Psychiatr Res","author":"VG Chittiprols","year":"2009","unstructured":"Chittiprols VG, Neelakantachar N, Babu SV, Reddy NA, Shetty KT, Gangadhar BN: Oxidative stress and neopterin abnormalities in Schizophrenia, A longitudinal study. J Psychiatr Res. 2009,"},{"key":"1462_CR18","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S0278-5846(01)00311-6","volume":"26","author":"K Yazici","year":"2002","unstructured":"Yazici K, Yazici AE, Taneli B: Different neuro-endocrine profiles of remitted and non-remitted schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry. 2002, 26: 579-584. 10.1016\/S0278-5846(01)00311-6.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1462_CR19","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1176\/appi.ajp.160.1.4","volume":"160","author":"R Kendell","year":"2003","unstructured":"Kendell R, Jablensky A: Distinguishing between the validity and utility of psychiatric diagnoses. Am J Psychiatry. 2003, 160: 4-12. 10.1176\/appi.ajp.160.1.4.","journal-title":"Am J Psychiatry"},{"key":"1462_CR20","first-page":"3660","volume":"21","author":"DS Young","year":"1975","unstructured":"Young DS, Pestaner LC, Gilberman U: Effects of drugs on clinical laboratory tests. Clin Chem. 1975, 21: 3660-","journal-title":"Clin Chem"},{"key":"1462_CR21","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1080\/09553009014552121","volume":"58","author":"R Varshney","year":"1990","unstructured":"Varshney R, Kale RK: Effect of calmodulin antagonist on radiation-induced lipid peroxidation in microsomes. Int J Radiat Biol. 1990, 58: 733-743. 10.1080\/09553009014552121.","journal-title":"Int J Radiat Biol"},{"key":"1462_CR22","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1006\/abio.1996.0292","volume":"239","author":"IE Benzie","year":"1996","unstructured":"Benzie IE, Strain JJ: The ferric reducing ability of plasma (FRAP) as a measure of antioxidant power (the FRAP assay). Anal Biochem. 1996, 239: 70-76. 10.1006\/abio.1996.0292.","journal-title":"Anal Biochem"},{"key":"1462_CR23","first-page":"563","volume":"133","author":"M Harma","year":"2003","unstructured":"Harma M, Harma M, Enel O: Increased oxidative stress in patients with hydatidiform mole. Swiss Med Wkly. 2003, 133: 563-566.","journal-title":"Swiss Med Wkly"},{"key":"1462_CR24","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0165-2478(00)00241-8","volume":"74","author":"A Wanchu","year":"2000","unstructured":"Wanchu A, Khullar M, Bhatnagar A, Sud A, Bambery P, Singh S: Pentoxiphylline Reduces Nitric Oxide Production among Patients with HIV Infection. Immunol Lett. 2000, 74: 121-125. 10.1016\/S0165-2478(00)00241-8.","journal-title":"Immunol Lett"},{"key":"1462_CR25","first-page":"24","volume":"S3","author":"MJ Lommen","year":"2009","unstructured":"Lommen MJ, Restifo K: Trauma and post traumatic stress disorder (PTSD) in patients with schizophrenia or schizoaffective disorder. Community Ment Health J. 2009, S3: 24-","journal-title":"Community Ment Health J"},{"key":"1462_CR26","first-page":"361","volume":"21","author":"O Kozumplik","year":"2009","unstructured":"Kozumplik O, Uzum S, Jakovljevic M: Psychotic disorders and Comorbidity somatic illness VS side effect. Psychiatr Danub. 2009, 21: 361-367.","journal-title":"Psychiatr Danub"},{"key":"1462_CR27","first-page":"1041","volume":"10","author":"A Tschoner","year":"2009","unstructured":"Tschoner A, Flexishhacker FWW, Ebenbichler CF: Experimental antipsycholtics and metabolic adverse effects - findings from clinical trials. Curr Opin Investig Drugs. 2009, 10: 1041-1048.","journal-title":"Curr Opin Investig Drugs"},{"key":"1462_CR28","doi-asserted-by":"publisher","first-page":"16","DOI":"10.4103\/0019-5545.39753","volume":"50","author":"G Dadheech","year":"2008","unstructured":"Dadheech G, Mishra S, Gautam S, Sharma P: Evaluation of antioxidant deficit in schizophrenia. Indian J Psychiatr. 2008, 50: 16-20. 10.4103\/0019-5545.39753.","journal-title":"Indian J Psychiatr"},{"key":"1462_CR29","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jad.2008.04.013","volume":"111","author":"AC Andreazza","year":"2008","unstructured":"Andreazza AC, Kauer-Sant' Anna M, Frey BN, Bond DJ, Kapezinski F, Young LT, Yatham LN: Oxidative stress markers in bipolar disorder; A metanalysi. J Affect Disord. 2008, 111: 135-144. 10.1016\/j.jad.2008.04.013.","journal-title":"J Affect Disord"},{"key":"1462_CR30","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.pnpbp.2009.06.018","volume":"33","author":"M Raffa","year":"2009","unstructured":"Raffa M, Mechri A, Othman LB, Fendri C, Gaha L, Kerkeni A: Decreased glutathione levels and antioxidant enzyme activities in untreated and treated schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry. 2009, 33: 1178-1183. 10.1016\/j.pnpbp.2009.06.018.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1462_CR31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/09540260600583072","volume":"18","author":"GE Berger","year":"2006","unstructured":"Berger GE, Sinesny S, Amminger GP: Bioactive lipids in schizophrenia. Int Rev Psychiatry. 2006, 18: 85-98. 10.1080\/09540260600583072.","journal-title":"Int Rev Psychiatry"},{"key":"1462_CR32","first-page":"173","volume":"38","author":"K Suboticanec","year":"1986","unstructured":"Suboticanec K, Vitamin C: status in schizophrenia. Bibl Nutr Dieta. 1986, 38: 173-181.","journal-title":"Bibl Nutr Dieta"},{"key":"1462_CR33","first-page":"23","volume":"4","author":"G Dadheech","year":"2005","unstructured":"Dadheech G, Mishra S, Gautam S, Sharma P: Oxidative stress and ascorbic acid status in schizophrenics. SFRR-Indian Bull. 2005, 4: 23-25.","journal-title":"SFRR-Indian Bull"},{"key":"1462_CR34","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/BF02912908","volume":"21","author":"G Dadheech","year":"2006","unstructured":"Dadheech G, Mishra S, Gautam S, Sharma P: Oxidative stress, \u03b1-tocopherol, ascorbic acid and reduced glutathione status in schizophrenics. Indian J Clin Biochem. 2006, 21: 34-38.","journal-title":"Indian J Clin Biochem"},{"key":"1462_CR35","first-page":"5","volume":"15","author":"T Whitford","year":"2000","unstructured":"Whitford T: The underlying mechanisms of brain allergies. J Orthomol Med. 2000, 15: 5-14.","journal-title":"J Orthomol Med"},{"key":"1462_CR36","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/0304-4165(89)90131-1","volume":"991","author":"K Uchida","year":"1989","unstructured":"Uchida K, Mitsui M, Kawakishi S: Mono-oxygenation of N-acetylhistamine mediated by Lascorbate. Biochim Biophys Acta. 1989, 991: 377-379. 10.1016\/0304-4165(89)90131-1.","journal-title":"Biochim Biophys Acta"},{"key":"1462_CR37","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/00004714-198904000-00011","volume":"9","author":"GM Straw","year":"1989","unstructured":"Straw GM, Bigelow LB, Kirch DG: Haloperidol and reduced haloperidol concentrations and psychiatric ratings in schizophrenic patients treated with ascorbic acid. J Clin Psychopharmacol. 1989, 9: 130-132. 10.1097\/00004714-198904000-00011.","journal-title":"J Clin Psychopharmacol"},{"key":"1462_CR38","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.schres.2005.05.019","volume":"78","author":"H Bernstein","year":"2005","unstructured":"Bernstein H, Bogerts B, Keilhoff G: The many faces of nitric oxide in schizophrenia. A Review. Schizophr Res. 2005, 78: 69-86. 10.1016\/j.schres.2005.05.019.","journal-title":"Schizophr Res"},{"key":"1462_CR39","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1089\/ars.2007.1511","volume":"9","author":"M Okouchi","year":"2007","unstructured":"Okouchi M, Ekshyyan O, Maracine M, Aw TY: Neuronal apoptosis in neurodegeneration. Antioxid Redox Signal. 2007, 9: 1060-1096.","journal-title":"Antioxid Redox Signal"},{"key":"1462_CR40","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/0014-5793(93)81706-6","volume":"334","author":"N Hogg","year":"1993","unstructured":"Hogg N, Kalyanaraman B, Joseph J, Struck A, Parthasarthy S: Inhibition of low-density lipoprotein oxidation by nitric oxide. FEBS Lett. 1993, 334: 170-174. 10.1016\/0014-5793(93)81706-6.","journal-title":"FEBS Lett"},{"key":"1462_CR41","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1515\/bchm3.1994.375.2.81","volume":"375","author":"JS Beckman","year":"1994","unstructured":"Beckman JS, Ye YZ, Anderson PG, Chen J, Accavitti MA, Tarpey MM, White CR: Extensive nitration of protein tyrosine in human atheroscerosis detected by immunohistochemistry. Biol Chem Hoppe Seyler. 1994, 375: 81-88.","journal-title":"Biol Chem Hoppe Seyler"},{"key":"1462_CR42","doi-asserted-by":"publisher","first-page":"219","DOI":"10.2174\/157340008786576553","volume":"4","author":"JP Oliveira","year":"2008","unstructured":"Oliveira JP, Zuardi AW, Hallak JE: Role of Nitric Oxide in Patients with Schizophrenia- a Systematic Review of the Literature. Curr Psychiatr Rev. 2008, 4: 219-227. 10.2174\/157340008786576553.","journal-title":"Curr Psychiatr Rev"},{"key":"1462_CR43","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0022-3956(02)00014-6","volume":"36","author":"SS Zoroglu","year":"2002","unstructured":"Zoroglu SS, Herken H, Y\u00fcrekli M, Uz E, Tutkun H, Sava\u015f HA, Bagci C, Ozen ME, Cengiz B, Cakmak EA, Dogru MI, Akyol O: The possible pathophysiological role of plasma nitric oxide and adrenomedullin in schizophrenia. J Psychiatr Res. 2002, 36: 309-315. 10.1016\/S0022-3956(02)00014-6.","journal-title":"J Psychiatr Res"},{"key":"1462_CR44","first-page":"641","volume":"1","author":"K Sim","year":"2002","unstructured":"Sim K, Chong SA, Chan YH, Lum NM: Thyroid dysfunction in chronic schizophrenia within a state psychiatric hospital. Ann Acad Med Singapore. 2002, 1: 641-644.","journal-title":"Ann Acad Med Singapore"},{"key":"1462_CR45","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0920-9964(99)00187-5","volume":"44","author":"A Baumgartner","year":"2000","unstructured":"Baumgartner A, Pietzcker A, Gaebel W: The hypothalamic-Pituitary-thyroid-axis in patients with schizophrenia. Schizophr Res. 2000, 44: 23-24.","journal-title":"Schizophr Res"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-0500-5-169.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1756-0500-5-169\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-0500-5-169.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T17:23:33Z","timestamp":1742837013000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/1756-0500-5-169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,31]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1462"],"URL":"https:\/\/doi.org\/10.1186\/1756-0500-5-169","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,31]]},"article-number":"169"}}